- Lannett Company (NYSE:LCI) has received the FDA approval for its Abbreviated New Drug Application for Dronabinol Capsules USP, 2.5 mg, 5 mg and 10 mg, the therapeutic equivalent to, Marinol Capsules 2.5 mg, 5 mg and 10 mg of AbbVie Inc.
- According to IMS, total U.S. sales of Dronabinol Capsules was ~$120M, for year ending March 31.